Given the growing healthcare burden related to chronic diseases, there is an evident need for safe, cost effective and convenient self-injecting devices in order to meet the demand need of frequent medication
Roots Analysis has announced the addition of “Autoinjector IP Landscape” report to its list of offerings.
The report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of autoinjectors and their components intended to offer safety features and patient compliance during self-administration of drugs. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain. Key inclusions are briefly described below:
Overall Intellectual Property Landscape
- An analytical perspective of the various patents and affiliated IP documents that have been published related to autoinjectors, since 1973. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this niche, but rapidly evolving segment of the biopharmaceutical industry.
Popular / Relevant Prior Art Search Expressions
- An examination of IP literature, shortlisting key words and phrases used to describe autoinjectors (and affiliated products) that are either already available in the market, or under development. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends.
Patent Valuation Analysis
- A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region).
Patentability and Freedom to Operate
- A systematic approach to identifying relevant areas of innovation by analyzing published IP documents (representative of unique patent families), by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.
Analysis of Patent Applications
- A detailed summary of the various patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of innovation and type of innovation (such as a product class, enabling technologies or method of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends.
Analysis of Granted Patents
- An analysis of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to autoinjectors, and the assessing likelihood for innovators to enter into promising research areas.
Pockets of Innovation and White Spaces
- An insightful analysis of the various CPC codes used in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on innovation and type of innovation) in this field of research.
Claim Analysis
- One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active autoinjectors patents (representative of unique patent families) in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim). A detailed assessment of the current market landscape of drug developers engaged in the development of next generation immune checkpoint modulators.
Key companies covered in the report
- Bristol Myers Squibb
- Sanofi
- Ypsomed
- Novo Nordisk
- Owen Mumford
- Becton Dickinson
- Janssen
- SHL Group
- Amgen
- Aptar Pharma
- UCB
- Meridian Medical
- Eli Lilly
- PHC technologies
- Ascendis Pharma
To view more details on this report, click on the link
You may also be interested in the following titles:
| Decentralized Clinical Trials / Virtual Clinical Trials Market |
| Global Antibiotics Market Bispecific Antibodies Market Digital Biomanufacturing Market |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
